OncoCyte Provides Updated Timelines on Diagnostic Test Development and Commercialization Plans
January 04, 2017 07:00 ET
|
OncoCyte Corporation
Breast Cancer Test Development Three to Six Months Ahead of Schedule; Commercial Launch Possible in Mid to Late 2018 Lung Cancer Test Development Two to Three Months Behind Schedule; Commercial...
OncoCyte Announces Publication of Breast Cancer Diagnostic Test Abstract; Poster to be Presented at the San Antonio Breast Cancer Symposium on December 9, 2016
November 14, 2016 16:01 ET
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, provided a summary of the...
OncoCyte Reports Third Quarter 2016 Financial Results
November 10, 2016 16:01 ET
|
OncoCyte Corporation
Currently Processing Samples and Analyzing Results in its Lung Cancer Test Study; Continues to Project a Completion Date in Late December Conference Call to Discuss the Results...
OncoCyte Promotes Lyndal Hesterberg to Senior Vice President, Research and Development
November 08, 2016 07:00 ET
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the early detection of cancer, today announced...
UPDATE -- OncoCyte to Report Third Quarter Financial Results on November 10, 2016
November 02, 2016 16:33 ET
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte to Report Third Quarter Financial Results on November 10, 2016
November 02, 2016 15:00 ET
|
Oncocyte Corporation
ALAMEDA, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that it...
OncoCyte Announces Sponsored Symposium at the 2016 American College of Chest Physician’s CHEST 2016 Annual Meeting
October 24, 2016 06:00 ET
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the detection of cancer, today announced that it...
OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHEST 2016 Annual Meeting
October 17, 2016 05:00 ET
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood-based tests for the early detection of cancer, and The Wistar...
OncoCyte Corporation to Present at the BIO Investor Forum
October 14, 2016 06:30 ET
|
Oncocyte Corporation
ALAMEDA, Calif., Oct. 14, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William...
OncoCyte Corporation to Present at the 2016 Aegis Growth Conference
September 20, 2016 06:30 ET
|
Oncocyte Corporation
ALAMEDA, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that William...